The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The role of STATs in transcriptional control and their impact on cellular function
Abstract
The STAT proteins (Signal Transducers and Activators of Transcription), were identified in the last decade as transcription factors which were critical in mediating virtually all cytokine driven signaling. These proteins are latent in the cytoplasm and become activated through tyrosine phosphorylation which typically occurs through cytokine receptor associated kinases (JAKs) or growth factor receptor tyrosine kinases. Recently a number of non-receptor tyrosine kinases (for example src and abl) have been found to cause STAT phosphorylation. Phosphorylated STATs form homo- or hetero-dimers, enter the nucleus and working coordinately with other transcriptional co-activators or transcription factors lead to increased transcriptional initiation. In normal cells and in animals, ligand dependent activation of the STATs is a transient process, lasting for several minutes to several hours. In contrast, in many cancerous cell lines and tumors, where growth factor dysregulation is frequently at the heart of cellular transformation, the STAT proteins (in particular Stats 1, 3 and 5) are persistently tyrosine phosphorylated or activated. The importance of STAT activation to growth control in experiments using anti-sense molecules or dominant negative STAT protein encoding constructs performed in cell lines or studies in animals lacking specific STATs strongly indicate that STATs play an important role in controlling cell cycle progression and apoptosis. Stat1 plays an important role in growth arrest, in promoting apoptosis and is implicated as a tumor suppressor; while Stats 3 and 5 are involved in promoting cell cycle progression and cellular transformation and preventing apoptosis. Many questions remain including: (1) a better understanding of how the STAT proteins through association with other factors increase transcription initiation; (2) a more complete definition of the sets of genes which are activated by different STATs and (3) how these sets of activated genes differ as a function of cell type. Finally, in the context of many cancers, where STATs are frequently persistently activated, an understanding of the mechanisms leading to their constitutive activation and defining the potential importance of persistent STAT activation in human tumorigenesis remains. Oncogene (2000).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-6 is also a key factor in inflammation, autoimmunity and cancer, with its effect mainly exerted through the IL-6–signal transducer and activator of transcription 3 (STAT3) pathway (18–26, 61–65).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [61]
In the citing paper
“HCV core protein interacts with the signal transducer and activator of transcription 3 (STAT3) protein36, a transcription factor involved in mediating cytokine signalling37.”
From Inflammation and cancer (2002) · cites this paper as [37]
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Self-citationWen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,539
A Matter of Life and Cell Death
Evan, G. I., & Littlewood, T. D. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,528
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Cited by
Sorted by citations
Items 101–200 of 1,000
STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers
Wang, X., Crowe, P. J., Goldstein, D., & Yang, J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1568 · Cited by 204
Kim, S. M., Kwon, O.-J., Hong, Y. K., Kim, J. H., Solca, F., Ha, S., Soo, R. A., Christensen, J. G., Lee, J. H., & Cho, B. C. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0311 · Cited by 203
STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC
Bu, L., Yu, G., Wu, L., Mao, L., Deng, W., Liu, J., Kulkarni, A. B., Zhang, W. F., Zhang, L., & Sun, Z. (2017) · Journal of Dental Research · doi:10.1177/0022034517712435 · Cited by 200
Hazan‐Halevy, I., Harris, D., Liu, Z., Liu, J., Li, P., Chen, X., Shanker, S., Ferrajoli, A., Keating, M. J., & Estrov, Z. E. (2010) · Blood · doi:10.1182/blood-2009-10-230060 · Cited by 209
Kovarik, P., Mangold, M., Ramsauer, K., Heidari, H., Steinborn, R., Zotter, A., Levy, D. E., Müller, M., & Decker, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.91 · Cited by 200
Roles and Regulation of Stat Family Transcription Factors in Human Breast Cancer
Clevenger, C. V. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63403-7 · Cited by 199
Dolled-Filhart, M. P., Camp, R. L., Kowalski, D. P., Smith, B. L., & Rimm, D. L. (2003) · PubMed · Cited by 196
Lin, L., Hutzen, B. J., Li, P., Ball, S. L., Zuo, M., Deangelis, S., Foust, E., Sobo, M., Friedman, L., Bhasin, D., et al. (2010) · Neoplasia · doi:10.1593/neo.91196 · Cited by 196
Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis
Zhang, Y.-W., Wang, L., Jove, R., & Woude, G. F. V. (2002) · Oncogene · doi:10.1038/sj.onc.1205004 · Cited by 203
Yu, L., Chen, C., Wang, L.-F., Kuang, X., Liu, K., Zhang, H., & Du, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055839 · Cited by 190
Lee, M.-H., & Yang, H. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000826 · Cited by 189
Role of JAK/STAT in the Neuroinflammation and its Association with Neurological Disorders
Jain, M., Singh, M. K., Shyam, H., Mishra, A., Kumar, S., Kumar, A., & Kushwaha, J. K. (2021) · Annals of Neurosciences · doi:10.1177/09727531211070532 · Cited by 196
The IKK-related kinases: from innate immunity to oncogenesis
Clément, J.-F., Meloche, S., & Servant, M. J. (2008) · Cell Research · doi:10.1038/cr.2008.273 · Cited by 189
Biological significance of c-erbB family oncogenes in head and neck cancer
Rogers, S. J., Harrington, K. J., Rhys‐Evans, P. H., O‐charoenrat, P., & Eccles, S. A. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-5047-1 · Cited by 184
Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer
You, S., Li, R., Park, D., Xie, M., Sica, G., Cao, Y., Xiao, Z., & Deng, X. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0608 · Cited by 184
Zhang, X., Yue, P., Fletcher, S., Zhao, W., Gunning, P. T., & Turkson, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.001 · Cited by 179
The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms
Liu, J., Wang, F., & Luo, F. (2023) · Biomolecules · doi:10.3390/biom13010119 · Cited by 188
Interleukin‐6 promotes tumorigenesis by altering DNA methylation in oral cancer cells
Gasche, J. A., Hoffmann, J., Boland, C. R., & Goel, A. (2011) · International Journal of Cancer · doi:10.1002/ijc.25764 · Cited by 178
Gewinner, C. A., Hart, G. W., Zachara, N. E., Cole, R. N., Beisenherz-Huss, C., & Groner, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306449200 · Cited by 187
Mocanu, M. M., Bell, R. M., & Yellon, D. M. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2006 · Cited by 177
STAT3 pathway in cancers: Past, present, and future
Wang, H., Man, Q., Huo, F., Gao, X., Lin, H., Li, S.-R., Wang, J., Su, F., Cai, L., Shi, Y., et al. (2022) · MedComm · doi:10.1002/mco2.124 · Cited by 175
Amin, H. M., McDonnell, T. J., Ma, Y., Lin, Q. D., Fujio, Y., Kunisada, K., Leventaki, V., Das, P., Rassidakis, G. Z., Cutler, C. S., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207703 · Cited by 175
FOXP1: a potential therapeutic target in cancer
Koon, H. B., Ippolito, G. C., Banham, A. H., & Tucker, P. W. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.7.955 · Cited by 169
Jung, J. E., Kim, G. S., Narasimhan, P., Song, Y. S., & Chan, P. H. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1110-09.2009 · Cited by 169
Jackson, S. H., Yu, C., Mahdi, R. M., Ebong, S., & Egwuagu, C. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2307 · Cited by 169
The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS
Chen, C.-D., Sloane, J. A., Li, H., Aytan, N., Giannaris, E. L., Zeldich, E., Hinman, J. D., Dedeoglu, A., Rosene, D. L., Bansal, R., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2080-12.2013 · Cited by 165
Dendritic Cells and Tumor Microenvironment: A Dangerous Liaison
Fricke, I., & Gabrilovich, D. I. (2006) · Immunological Investigations · doi:10.1080/08820130600803429 · Cited by 172
PRL Activates the Cyclin D1 Promoter Via the Jak2/Stat Pathway
Brockman, J. L., Schroeder, M. D., & Schuler, L. A. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.4.0817 · Cited by 170
Signaling at zero G: G-protein-independent functions for 7-TM receptors
Brzostowski, J. A., & Kimmel, A. R. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01804-7 · Cited by 162
STAT3 and its targeting inhibitors in osteosarcoma
Liu, Y., Liao, S., Bennett, S., Tang, H., Song, D., Wood, D., Zhan, X., & Xu, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12974 · Cited by 163
IL-10 Induces IL-10 in Primary Human Monocyte-Derived Macrophages via the Transcription Factor Stat3
Staples, K. J., Smallie, T., Williams, L. M., Foey, A., Burke, B., Foxwell, B. M. J., & Ziegler‐Heitbrock, L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4779 · Cited by 159
Frieman, M. B., Chen, J., Morrison, T. E., Whitmore, A., Funkhouser, W., Ward, J. M., Lamirande, E. W., Roberts, A., Heise, M., Subbarao, K., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000849 · Cited by 158
Werme, K., Wigerius, M., & Johansson, M. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01076.x · Cited by 164
Role of Signal Transducer and Activator of Transcription 3 in Neuronal Survival and Regeneration
Dziennis, S., & Alkayed, N. J. (2008) · Reviews in the Neurosciences · doi:10.1515/revneuro.2008.19.4-5.341 · Cited by 166
Napabucasin: an update on the first-in-class cancer stemness inhibitor
Hubbard, J. M., & Grothey, A. (2017) · Drugs · doi:10.1007/s40265-017-0759-4 · Cited by 157
STAT3 Phosphorylation at Tyrosine 705 and Serine 727 Differentially Regulates Mouse ESC Fates
Huang, G., Yan, H., Ye, S., Tong, C., & Ying, Q. (2013) · Stem Cells · doi:10.1002/stem.1609 · Cited by 166
Metal complexes as potential modulators of inflammatory and autoimmune responses
Leung, C., Lin, S., Zhong, H., & Ma, D. (2014) · Chemical Science · doi:10.1039/c4sc03094j · Cited by 156
STAT5‐induced Id‐1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPβ
Xu, M. J., Nie, L., Kim, S., & Sun, X. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg094 · Cited by 157
STAT1 acts as a tumor promoter for leukemia development
Kovačic, B., Stoiber, D., Moriggl, R., Weisz, E., Ott, R. G., Kreibich, R., Levy, D. E., Beug, H., Freissmuth, M., & Sexl, V. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.025 · Cited by 155
Zinc transporter SLC39A10/ZIP10 facilitates antiapoptotic signaling during early B-cell development
Miyai, T., Hojyo, S., Ikawa, T., Kawamura, M., Irié, T., Ogura, H., Hijikata, A., Bin, B.-H., Yasuda, T., Kitamura, H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323549111 · Cited by 157
Zhang, X., Tian, W., Cai, X., Wang, X., Dang, W., Tang, H., Cao, H., Wang, L., & Chen, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065896 · Cited by 153
Viral Carcinogenesis: Factors Inducing DNA Damage and Virus Integration
Chen, Y., Williams, V. M., Filippova, M., Filippov, V. A., & Duerksen-Hughes, P. J. (2014) · Cancers · doi:10.3390/cancers6042155 · Cited by 151
Molecular Biology of Head and Neck Cancer
Lam, D. K., & Schmidt, B. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-2527-6.00010-4 · Cited by 151
Current Understanding on EGFR and Wnt/ -Catenin Signaling in Glioma and Their Possible Crosstalk
Paul, I., Bhattacharya, S., Chatterjee, A., & Ghosh, M. K. (2013) · Genes & Cancer · doi:10.1177/1947601913503341 · Cited by 158
The Role of STAT-3 in the Induction of Apoptosis in Pancreatic Cancer Cells by Benzyl Isothiocyanate
Sahu, R. P., & Srivastava, S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn470 · Cited by 150
Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
Parikh, K., Cang, S., Sekhri, A., & Liu, D. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0078-0 · Cited by 148
Rajendran, P., Li, F., Shanmugam, M. K., Vali, S., Abbasi, T., Kapoor, S., Ahn, K. S., Kumar, A. P., & Sethi, G. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22954 · Cited by 148
Gu, M., Singh, R. P., Dhanalakshmi, S., Agarwal, C., & Agarwal, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3955 · Cited by 148
Reprogramming of IL-10 Activity and Signaling by IFN-γ
Herrero, C., Hu, X., Li, W. P., Samuels, S., Sharif, M. N., Kotenko, S. V., & Ivashkiv, L. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5034 · Cited by 152
Andl, C. D., Mizushima, T., Oyama, K., Bowser, M., Nakagawa, H., & Rustgi, A. K. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00253.2004 · Cited by 146
Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells
Behera, R., Kumar, V., Lohite, K., Karnik, S., & Kundu, G. C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp289 · Cited by 146
An overview of transcriptional regulation in response to toxicological insult
Jennings, P., Limonciel, A., Felice, L., & Leonard, M. O. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0919-y · Cited by 147
Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
Beebe, J., Liu, J., & Zhang, J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.006 · Cited by 144
Timofeeva, O. A., Tarasova, N. I., Zhang, X., Chasovskikh, S., Cheema, A. K., Wang, H., Brown, M. L., & Dritschilo, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211805110 · Cited by 142
Lim, W.-S., Timmins, J. M., Seimon, T. A., Sadler, A. J., Kolodgie, F. D., Virmani, R., & Tabas, I. A. (2008) · Circulation · doi:10.1161/circulationaha.107.711275 · Cited by 147
Activation of the STAT1 pathway in rheumatoid arthritis
Kasperkovitz, P. V., Verbeet, N. L., Smeets, T. J. M., van Rietschoten, J. G. I., Kraan, M. C., Kraan, T. C. T. M. V. D. P., Tak, P. P., & Verweij, C. L. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.013276 · Cited by 141
Ning, Z.-Q., Li, J., & Arceci, R. J. (2001) · Blood · doi:10.1182/blood.v97.11.3559 · Cited by 138
Li, L., Hooi, D. S. W., Chhabra, S. R., Pritchard, D., & Shaw, P. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207612 · Cited by 137
Yun, J., Park, S. W., Kim, K., Bae, J., Lee, E. H., Paek, S. H., Kim, S. U., Ye, S., Kim, J. H., & Cho, C. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25575 · Cited by 136
van Erk, M. J., Roepman, P., van der Lende, T. R., Stierum, R. H., Aarts, J. M. M. J. G., van BLADEREN, P. J., & van Ommen, B. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-0503-1 · Cited by 136
Rosen, D. G., Mercado‐Uribe, I., Yang, G. S., Bast, R. C., Amin, H. M., Lai, R. L., & Liu, J. (2006) · Cancer · doi:10.1002/cncr.22293 · Cited by 133
Bi, Y., Min, M., Shen, W., & Liu, Y. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.12.001 · Cited by 132
Jing, N., Li, Y., Xiong, W., Sha, W., Jing, L., & Tweardy, D. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4041 · Cited by 132
Ma, K., Ivanov, V. N., Dong, J., & Ronai, Z. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206598 · Cited by 132
Role of platelets on liver regeneration after 90% hepatectomy in mice
Myronovych, A., Murata, S., Chiba, M., Matsuo, R., Ikeda, O., Watanabe, M., Hisakura, K., Nakano, Y., Kohno, K., Kawasaki, T., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.04.019 · Cited by 131
Ram, P. T., & Iyengar, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204186 · Cited by 132
Gao, L., Zhang, L., Hu, J., Li, F., Shao, Y., Zhao, D., Kalvakolanu, D. V., Kopecko, D. J., Zhao, X., & Xu, D.-Q. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0148 · Cited by 131
STAT3, a master regulator of anti-tumor immune response
Rébé, C., & Ghiringhelli, F. (2019) · Cancers · doi:10.3390/cancers11091280 · Cited by 129
Opposing roles of STAT1 and STAT3 in IL-21 function in CD4 + T cells
Wan, E. C. K., Andraski, A. B., Spolski, R. J., Li, P., Kazemian, M., Oh, J., Samsel, L., Swanson, P. A., McGavern, D. B., Sampaio, E. P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511711112 · Cited by 133
STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
Laudisi, F., Cherubini, F., Monteleone, G., & Stolfi, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061787 · Cited by 133
Identification of a High-Affinity Phosphopeptide Inhibitor of Stat3
Ren, Z., Cabell, L. A., Schaefer, T. S., & McMurray, J. S. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01050-8 · Cited by 128
Loss of Tolerance and Autoimmunity Affecting Multiple Organs in STAT5A/5B -Deficient Mice
Snow, J. W., Abraham, N., Ma, M. C., HERNDIER, B. G., Pastuszak, A. W., & Goldsmith, M. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5042 · Cited by 128
Proietti, C. J., Salatino, M., Rosemblit, C., Carnevale, R. P., Pecci, A., Kornblihtt, A. R., Molinolo, A., Frahm, I., Charreau, E. H., Schillaci, R., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4826-4840.2005 · Cited by 130
Nagel‐Wolfrum, K., Buerger, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.170.2.3 · Cited by 132
Niu, G., Shain, K. H., Huang, M., Ravi, R. K., Bedi, A., Dalton, W. S., Jove, R., & Yu, H. (2001) · PubMed · Cited by 127
An essential role for SRC-activated STAT-3 in 14,15-EET–induced VEGF expression and angiogenesis
Cheranov, S. Y., Karpurapu, M., Wang, D., Zhang, B., Venema, R. C., & Rao, G. N. (2008) · Blood · doi:10.1182/blood-2007-11-126680 · Cited by 131
Coleman, Ren, Z., Mandal, P. K., Cameron, A. G., Dyer, G. A., Muranjan, S., Campbell, M. L., Chen, X., & McMurray, J. S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050513m · Cited by 128
IL-21: a novel IL-2–family lymphokine that modulates B, T, and natural killer cell responses
Habib, T., Nelson, A., & Kaushansky, K. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.039 · Cited by 126
STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
Kim, J., Patel, M. A., Ruzevick, J., Jackson, C. M., & Lim, M. K. (2014) · Cancers · doi:10.3390/cancers6010376 · Cited by 128
Wright, J. H., Wang, X., Manning, G., LaMere, B. J., Le, P., Zhu, S., Khatry, D., Flanagan, P. M., Buckley, S. D., Whyte, D. B., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.2068-2082.2003 · Cited by 126
Huang, M., Dorsey, J. F., Epling‐Burnette, P. K., Nimmanapalli, R., Landowski, T. H., Mora, L. B., Niu, G., Sinibaldi, D., Bai, F., Kraker, A. J., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1206028 · Cited by 126
Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation
Schuringa, J.-J., Schepers, H., Vellenga, E., & Kruijer, W. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02354-7 · Cited by 124
Fujiyoshi, M., & Ozaki, M. (2010) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-010-0304-2 · Cited by 129
Snow, J. W., Abraham, N. B., Ma, M. C., Abbey, N. W., HERNDIER, B. G., & Goldsmith, M. A. (2002) · Blood · doi:10.1182/blood.v99.1.95 · Cited by 124
Oncogenic Potential of Hepatitis C Virus Proteins
Banerjee, A. K., Ray, R. B., & Ray, R. (2010) · Viruses · doi:10.3390/v2092108 · Cited by 126
Shu Dong, X. I. A. O., Li, D., Zhu, H., Song, M.-G., Pan, X., Jia, P.-M., Peng, L.-L., Dou, A., Chen, G., Chen, S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607830103 · Cited by 123
Tan, M., Lan, K., Yao, J., Lu, C., Sun, M., Neal, C. L., Lü, J., & Yu, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2747 · Cited by 123
Rahmani, A. H., Alzohairy, M. A., Khan, M. A., & Aly, S. M. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/724658 · Cited by 124
Toyonaga, T., Nakano, K., Nagano, M., Zhao, G., Yamaguchi, K., Kuroki, S., Eguchi, T., Chijiiwa, K., Tsuneyoshi, M., & Tanaka, M. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00482-8 · Cited by 122
Waiboci, L. W., Ahmed, C. M. I., Mujtaba, M. G., Flowers, L. O., Martin, J. P., Haider, M. I., & Johnson, H. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5058 · Cited by 122
STAT1-induced Apoptosis Is Mediated by Caspases 2, 3, and 7
Sironi, J., & Ouchi, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307774200 · Cited by 123
Chen, H., Yang, Z., Ding, C., Chu, L., Zhang, Y., Terry, K., Liu, H., Shen, Q., & Zhou, J. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3003082 · Cited by 121
STAT3 and STAT5 Activation in Solid Cancers
Igelmann, S., Neubauer, H. A., & Ferbeyre, G. (2019) · Cancers · doi:10.3390/cancers11101428 · Cited by 120
Cancer-Derived Exosomes as Effectors of Key Inflammation-Related Players
Othman, N., Jamal, R., & Abu, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02103 · Cited by 121
Singh, N., Lawana, V., Luo, J. D., Phong, P., Abdalla, A., Palanisamy, B. N., Rokad, D., Sarkar, S., Jin, H., Anantharam, V., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.019 · Cited by 120
Haroon, F., Drögemüller, K., Händel, U., Brunn, A., Reinhold, D., Nishanth, G., Müller, W., Trautwein, C., Ernst, M., Deckert, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001135 · Cited by 122
Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
Li, S., Priceman, S. J., Xin, H., Zhang, W., Deng, J., Liu, Y., Huang, J., Zhu, W., Chen, M., Hu, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081657 · Cited by 117
Epidermal growth factor receptor-targeted therapy for pancreatic cancer
XIONG, H., & Abbruzzese, J. L. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70088-2 · Cited by 117
Interferon‐γ‐induced chromatin remodeling at the CIITA locus is BRG1 dependent
Pattenden, S. G., Klose, R. J., Karaskov, E., & Bremner, R. (2002) · The EMBO Journal · doi:10.1093/emboj/21.8.1978 · Cited by 116
Nicot, C., Mulloy, J. C., Ferrari, M. G., Johnson, J. M., Fu, K., Fukumoto, R., Trovato, R., Fullen, J., Leonard, W. J., & Franchini, G. (2001) · Blood · doi:10.1182/blood.v98.3.823 · Cited by 116
Metadata
- Authors
- Bromberg, J., & Darnell, J. E.
- Affiliations
- Rockefeller University (US)
- ORCID
- Bromberg, Jacqueline
- Venue
- Oncogene
- Published
- 2000-05-25
- Volume
- 19
- Issue
- 21
- Pages
- 2468-2473
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1977681992
- Cited by
- 1,201
- References
- 66
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 21 · 2023: 24 · 2022: 37 · 2021: 40 · 2020: 46 · 2019: 41 · 2018: 42 · 2017: 51 · 2016: 46 · 2015: 49 · 2014: 59 · 2013: 67 · 2012: 56
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- STAT proteins, transcriptional regulation, cytokine signaling, JAK kinases, tyrosine phosphorylation, STAT1, STAT3, STAT5, cell cycle progression, apoptosis, tumor suppressor, cell transformation, carcinogenesis, transcriptional coactivator
- MeSH terms
- Animals, Cell Division, Cell Transformation, Neoplastic, DNA-Binding Proteins, Gene Expression Regulation, Humans, Milk Proteins, Neoplasms, Structure-Activity Relationship, Transcription, Genetic, Trans-Activators, STAT1 Transcription Factor, STAT3 Transcription Factor, STAT5 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
